Medical TV Dramas May Be Skewing Patient Expectations
"Night Shift" Video Game May Aid Physician Decision Making
Experts Pick the Top 10 Medical Innovations for 2018

Many of the treated patients were able to tolerate 300mg, 600mg, and 1000mg doses of peanut protein...

Results showed that 76.6%, 67.2%, and 50.3% (all P<0.00001) of the AR101 patients were able to tolerate 300mg, 600mg, and 1000mg of single dose of peanut protein. This is compared to 8.1%, 4.0% and 2.4% (all P<0.00001) of the placebo patients.

The Advisory Committee on Immunization Practices took a vote on the use of Heplisav-B for infection prevention...

he Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has voted in favor of Heplisav-B (hepatitis B vaccine [recombinant], adjuvanted) for use in the prevention of infection caused by all known subtypes of hepatitis B virus.

A total of 28 people from 20 states have been infected with this outbreak strain of Salmonella...

The CDC says the epidemiologic evidence indicates kratom as the likely source of the outbreak, while common source has been identified yet. The illnesses begin in October 2017 and have been recorded up to January 30 2018.
It looks like you may be having problems playing this video. If so, please try restarting your browser.

Imfinzi is a programmed death-ligand 1 (PD-L1) blocking antibody:

AstraZeneca and MedImmune announced that the Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiati...

Most patients respond to standard therapy but 5-10% of patients remain uncontrolled despite escalation of treatment:

Severe asthma is a challenging condition. Available therapeutic options for severe asthma include tiotropium, omalizumab, interleukin-5 targeted therapies, macrolide antibiotics, and bronchial thermoplasty.

ICYMI — The indicator works by measuring Ubiquitin Carboxy-terminal Hydrolase-L1 and Glial Fibrilliary Acidic Protein...

The Food and Drug Administration (FDA) has approved the Banyan Brain Trauma Indicator, the first blood test to evaluate mild traumatic brain injury (mTBI)

ICYMI — How light may help kill influenza virus:

According to a new study published in Scientific Reports, airborne flu viruses were safely and effectively eradicated with continuous low doses of far ultr

The study included 519,272 patients who used sulfonylureas.

After examining the association between antidiabetic sulfonylureas and sudden cardiac arrest and ventricular arrhythmia (SCA/VA), study authors reported gl

Heightened influenza activity expected to continue...

The Centers for Disease Control and Prevention (CDC) issued a surveillance report on recent influenza activity. In the U.S., cases of influenza started to

"A blood-testing option for evaluation of mTBI/concussion [...] sets the stage for a more modernized standard of care for testing of suspected cases," Scott Gottlieb, FDA Commissioner

The Food and Drug Administration (FDA) has approved the Banyan Brain Trauma Indicator, the first blood test to evaluate mild traumatic brain injury (mTBI)

This is the first FDA-approved therapy for this indication...

Erleada (apalutamide) has been approved as the first treatment for patients with non-metastatic, castration-resistant prostate cancer. The Food and Drug

A parent administered an hydrogen peroxide enema to children in an attempt to treat constipation...

Hydrogen peroxide enemas often pop up among the search results when people search for constipation treatments, however, a recent case report highlights the

A total of 1,350 individuals with early stage Alzheimer's disease were randomized to verubecestat or placebo...

Merck announced the discontinuation of the Phase 3 APECS study (protocol 019) evaluating verubecestat (MK-8931) for the treatment of patients with prodromal Alzheimer's disease

By blocking the "high" sensation, recovering addicts may not be as motivated to relapse into using the drug.

A novel vaccine to treat both heroin addiction and block lethal overdose may be nearly ready for human testing, according to researchers at The Scripps Res

A total of 241,251 adults with newly diagnosed depression were assessed for this study:

The researchers found that only 35.7% of individuals initiated treatment. These odds were ≤30% among Asians, non-Hispanics blacks, and Hispanics compared to non-Hispanic whites, after controlling for other variables.